Richard Van

Statistics

Publications

Citations

163

H-Index

Active since

2020

Affiliations

UCSF Helen Diller Family Comprehensive Cancer Center(Current)

New York University

Icahn School of Medicine at Mount Sinai

University of California, Davis

University of California, San Francisco

Richard Van is an author at UCSF Helen Diller Family Comprehensive Cancer Center specializing in life sciences, ras-mitogen-activated protein kinase signaling, and signal transduction.

ORCID

Publications per year

2020–2025

Publications

Expansion of tumor-reactive CD8 <sup>+</sup> T cell clonotypes occurs in the spleen in response to immune checkpoint blockade

Duncan M. Morgan, Brendan Horton, Vidit Bhandarkar et al. · Science Immunology · 2024 · 49 citations · Full text

Life Sciences, Immunology, Oncology +15

The RAS GTPase RIT1 compromises mitotic fidelity through spindle assembly checkpoint suppression

Antonio Cuevas-Navarro, Richard Van, Alice Cheng et al. · Current Biology · 2021 · 28 citations · Full text

Life Sciences, Genetics, Cell Division +14

RAS-dependent RAF-MAPK hyperactivation by pathogenic RIT1 is a therapeutic target in Noonan syndrome–associated cardiac hypertrophy

Antonio Cuevas-Navarro, Morgan E. Wagner, Richard Van et al. · Science Advances · 2023 · 24 citations · Full text

Life Sciences, Cardiology, Molecular Biology +17

Genetic deletion of Urocortin 3 does not prevent functional maturation of beta cells

Jessica L. Huang, Sharon Lee, Pelle Hoek et al. · Journal of Endocrinology · 2020 · 17 citations · Full text

Life Sciences, Endocrinology, Physiology +10

The seventh international <scp>RASopathies</scp> symposium: Pathways to a cure—expanding knowledge, enhancing research, and therapeutic discovery

Maria Kontaridis, Amy E. Roberts, Lisa Schill et al. · American Journal of Medical Genetics Part A · 2022 · 16 citations · Full text

Medicine, Molecular Medicine, Pharmacotherapy +13

1–5 of 7